These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30429286)

  • 1. The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands.
    Gfeller D; Guillaume P; Michaux J; Pak HS; Daniel RT; Racle J; Coukos G; Bassani-Sternberg M
    J Immunol; 2018 Dec; 201(12):3705-3716. PubMed ID: 30429286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
    Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
    J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
    Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
    J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large fraction of HLA class I ligands are proteasome-generated spliced peptides.
    Liepe J; Marino F; Sidney J; Jeko A; Bunting DE; Sette A; Kloetzel PM; Stumpf MP; Heck AJ; Mishto M
    Science; 2016 Oct; 354(6310):354-358. PubMed ID: 27846572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.
    Klar R; Schober S; Rami M; Mall S; Merl J; Hauck SM; Ueffing M; Admon A; Slotta-Huspenina J; Schwaiger M; Stevanović S; Oostendorp RA; Busch DH; Peschel C; Krackhardt AM
    Leukemia; 2014 Dec; 28(12):2355-66. PubMed ID: 24736212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.
    Gnjatic S; Atanackovic D; Matsuo M; Jäger E; Lee SY; Valmori D; Chen YT; Ritter G; Knuth A; Old LJ
    J Immunol; 2003 Feb; 170(3):1191-6. PubMed ID: 12538675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering complex patterns of class-I HLA-peptide cross-reactivity via hierarchical grouping.
    Mukherjee S; Warwicker J; Chandra N
    Immunol Cell Biol; 2015 Jul; 93(6):522-32. PubMed ID: 25708537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses.
    Rao X; Costa AI; van Baarle D; Kesmir C
    J Immunol; 2009 Feb; 182(3):1526-32. PubMed ID: 19155500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
    Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
    J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I supertypes: a revised and updated classification.
    Sidney J; Peters B; Frahm N; Brander C; Sette A
    BMC Immunol; 2008 Jan; 9():1. PubMed ID: 18211710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population response analysis approach to assign class II HLA-epitope restrictions.
    Paul S; Dillon MBC; Arlehamn CSL; Huang H; Davis MM; McKinney DM; Scriba TJ; Sidney J; Peters B; Sette A
    J Immunol; 2015 Jun; 194(12):6164-6176. PubMed ID: 25948811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.
    Zarling AL; Ficarro SB; White FM; Shabanowitz J; Hunt DF; Engelhard VH
    J Exp Med; 2000 Dec; 192(12):1755-62. PubMed ID: 11120772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions.
    Bassani-Sternberg M; Gfeller D
    J Immunol; 2016 Sep; 197(6):2492-9. PubMed ID: 27511729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.